Lidocaïne Hcl B. Braun

Lidocaine, the active ingredient in Lidocaïne Hcl B. Braun, is a local anesthetic presented as a sterile injectable solution for intravenous use. It provides rapid onset of numbness for local and regional anesthesia procedures in adult patients. GNH USA supplies Lidocaïne Hcl B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lidocaine is used in the management of pain by blocking nerve conduction in the peripheral nervous system. - Local anesthesia: provides targeted numbness for minor surgical or diagnostic procedures. - Regional anesthesia: enables anesthesia of larger body regions such as limbs or trunk during orthopedic or obstetric surgery. - Dental procedures: facilitates pain control during tooth extractions, root canals and other dental interventions.

Lidocaine may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Hypotension: transient drop in blood pressure after rapid intravenous administration. - Bradycardia: slowed heart rate, especially in patients with pre‑existing conduction abnormalities. - Metallic taste: transient metallic sensation in the mouth. - Nausea: mild gastrointestinal upset. - Dizziness: light‑headed feeling during or shortly after injection.

Serious or Rare Side Effects: - Seizures: central nervous system excitation at high plasma concentrations. - Cardiac arrhythmias: ventricular or supraventricular tachyarrhythmias. - Anaphylaxis: severe allergic reaction with respiratory compromise. - Methemoglobinemia: reduced oxygen‑carrying capacity of blood. - Respiratory depression: marked decrease in breathing effort.

Lidocaine should be administered with careful assessment of patient‑specific risk factors and monitoring. - Allergy assessment: verify no known hypersensitivity to lidocaine or other amide‑type anesthetics. - Cardiovascular status: monitor patients with heart block, severe conduction disorders, or low cardiac output. - Dosage limits: adhere to recommended maximum dose to avoid systemic toxicity. - Concurrent CNS depressants: use caution when combined with agents that lower seizure threshold. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in original container, protect from light and moisture.

Lidocaine can interact with several drug classes, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increase risk of cardiotoxicity. - Beta‑blockers: may exacerbate bradycardia and hypotension. - CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): raise plasma lidocaine concentrations.

Moderate Interactions (Monitor Closely): - Other local anesthetics: additive toxicity when used concurrently. - Diuretics (e.g., furosemide): may alter plasma protein binding and increase free lidocaine. - General anesthetics (e.g., propofol, volatile agents): may potentiate central nervous system depression.